These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34493032)

  • 1. A COVID-19 first evaluation clinic at a university hospital in Turkey.
    Telli Dizman G; Metan G; Ayaz Ceylan ÇM; Altunay H; Uzun M; Gürsoy G; Taş Z; Karahan G; Ahmadova F; Sarıcaoğlu T; Çalışkan ZC; Alp A; Sönmezler M; İnkaya A; Özyavuz Alp Ş; Uyaroğlu O; Er A; Özyavuz Alp Ş; Uyaroğlu O; Durusu Tanriöver M; Çalık Başaran N; Durhan G; Demirkazık F
    Turk J Med Sci; 2022 Feb; 52(1):1-10. PubMed ID: 34493032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of SARS-CoV-2 PCR Positive Cases in the Pediatric Emergency Department].
    Şık N; Özlü C; Karaoğlu Asrak H; Erbaş İC; Çakıl Güzin A; Atakul G; Atay Ö; Appak Ö; Sayıner AA; Uzuner N; Asilsoy S; Belet N; Yılmaz D; Duman M
    Mikrobiyol Bul; 2020 Oct; 54(4):629-637. PubMed ID: 33107292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surfaces and equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the emergency department at a university hospital.
    Peyrony O; Ellouze S; Fontaine JP; Thegat-Le Cam M; Salmona M; Feghoul L; Mahjoub N; Mercier-Delarue S; Gabassi A; Delaugerre C; Le Goff J;
    Int J Hyg Environ Health; 2020 Sep; 230():113600. PubMed ID: 32799101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perinatology clinic in the coronavirus disease-2019 pandemic: what harms, often teaches.
    Yapar Eyi EG; Moraloglu Tekin O; Buglagil A; Sahin D; Yucel A; Tanacan A; Halici Ozturk F; Yakistiran B; Yucel Yetiskin D; Unlu S; Gokcinar D
    J Matern Fetal Neonatal Med; 2021 Nov; 34(21):3591-3600. PubMed ID: 33645392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Letter to the Editor: THE IMPACT OF THE COVID-19 PANDEMIC ON SCHIZOPHRENIA PATIENTS.
    Hoşgelen EI; Alptekin K
    Turk Psikiyatri Derg; 2021; 32(3):219-221. PubMed ID: 34637131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Letter to the Editor: THE IMPACT OF THE COVID-19 PANDEMIC ON SCHIZOPHRENIA PATIENTS.
    Hoşgelen EI; Alptekin K
    Turk Psikiyatri Derg; 2021; 32(3):219-221. PubMed ID: 34750798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection and evaluation of SARS-CoV-2 nucleic acid contamination in corona virus disease 19 ward surroundings and the surface of medical staff's protective equipment].
    Yuan XN; Meng QY; Shen N; Li YX; Liang C; Cui M; Ge QG; Li XG; Tan K; Chen Q; Wang J; Zeng XY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 52(5):803-808. PubMed ID: 33047711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modelling of hypothetical SARS-CoV-2 point-of-care tests on admission to hospital from A&E: rapid cost-effectiveness analysis.
    Stevenson M; Metry A; Messenger M
    Health Technol Assess; 2021 Mar; 25(21):1-68. PubMed ID: 33764295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective analysis of the first 50 emergency/elective surgical cases in terms of mortality and morbidity in CoVid-19 Pandemic Hospital in Istanbul.
    Peksen C; Aktokmakyan TV; Savas OA; Datli A; Nurili F; Yurdaisik I; Bozkurtgil N; Yavuz F; Sumer A
    Ann Ital Chir; 2020; 91():563-567. PubMed ID: 33554942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Containment of a healthcare-associated COVID-19 outbreak in a university hospital in Seoul, Korea: A single-center experience.
    Kim SW; Jo SJ; Lee H; Oh JH; Lim J; Lee SH; Choi JH; Lee J
    PLoS One; 2020; 15(8):e0237692. PubMed ID: 32797094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of the Rapid Antigen Detection Kit with the Polymerase Chain Reaction for Detection of SARS-CoV-2 in Respiratory Samples].
    Erman Daloğlu A; Er H; Sepin Özen N; Çekin Y
    Mikrobiyol Bul; 2022 Apr; 56(2):263-273. PubMed ID: 35477229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and Unexpected COVID-19 Diagnoses in Resuscitation Room Patients during the COVID-19 Outbreak-A Retrospective Case Series.
    Bergrath S; Aretz O; Haake H; Ringelstein A; Greiffendorf I; Graeven U; Windfuhr J
    Biomed Res Int; 2020; 2020():2721381. PubMed ID: 32884938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-infection of COVID-19 and influenza A in a hemodialysis patient: a case report.
    Jing R; Vunnam RR; Schnaubelt E; Vokoun C; Cushman-Vokoun A; Goldner D; Vunnam SR
    BMC Infect Dis; 2021 Jan; 21(1):68. PubMed ID: 33441085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
    Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
    Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease.
    Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Dittrich S; Domen J; Horn SRA; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD013665. PubMed ID: 32633856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.
    Lyngbakken MN; Berdal JE; Eskesen A; Kvale D; Olsen IC; Rangberg A; Jonassen CM; Omland T; Røsjø H; Dalgard O
    Trials; 2020 Jun; 21(1):485. PubMed ID: 32503662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Environmental detection of SARS-CoV-2 in hospital rooms in different wards of a university hospital.
    Barrigah-Benissan K; Ory J; Boudet A; Stephan R; Sotto A; Lavigne JP
    J Hosp Infect; 2022 Oct; 128():74-79. PubMed ID: 35944790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.